Cetera Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$9.23M Buy
97,284
+40,184
+70% +$3.73M 0.07% 274
2023
Q4
$5.1M Buy
57,100
+207
+0.4% +$15.4K 0.07% 276
2023
Q3
$4.15M Sell
56,893
-556
-1% -$44.4K 0.06% 290
2023
Q2
$4.78M Sell
57,449
-1,789
-3% -$150K 0.08% 246
2023
Q1
$4.51M Sell
59,238
-6,016
-9% -$499K 0.08% 264
2022
Q4
$5.42M Buy
65,254
+2,258
+4% +$183K 0.1% 218
2022
Q3
$5M Buy
62,996
+9,049
+17% +$763K 0.13% 173
2022
Q2
$4.01M Buy
53,947
+496
+0.9% +$37.2K 0.09% 228
2022
Q1
$4.8M Buy
53,451
+12,170
+29% +$1.12M 0.1% 221
2021
Q4
$4.62M Buy
41,281
+4,792
+13% +$578K 0.09% 221
2021
Q3
$4.59M Buy
36,489
+892
+3% +$115K 0.09% 232
2021
Q2
$4.82M Buy
35,597
+6,528
+22% +$858K 0.11% 190
2021
Q1
$3.94M Buy
29,069
+18,549
+176% +$2.78M 0.11% 195
2020
Q4
$1.48M Buy
10,520
+7,404
+238% +$948K 0.05% 331
2020
Q3
$347K Buy
+3,116
New +$349K 0.01% 684
2019
Q3
Sell
-2,484
Closed -$219K 974
2019
Q2
$219K Buy
2,484
+389
+19% +$33.2K 0.01% 826
2019
Q1
$191K Buy
+2,095
New +$178K 0.01% 796
2018
Q4
Sell
-3,061
Closed -$294K 976
2018
Q3
$294K Buy
+3,061
New +$297K 0.01% 732
2017
Q2
Sell
-3,361
Closed -$234K 869
2017
Q1
$234K Sell
3,361
-1,041
-24% -$69.9K 0.02% 657
2016
Q4
$261K Sell
4,402
-73
-2% -$4.51K 0.02% 554
2016
Q3
$295K Sell
4,475
-600
-12% -$37.1K 0.02% 565
2016
Q2
$275K Sell
5,075
-55
-1% -$3.01K 0.02% 587
2016
Q1
$262K Sell
5,130
-519
-9% -$27K 0.02% 561
2015
Q4
$398K Buy
+5,649
New +$385K 0.03% 459
2015
Q3
Sell
-8,433
Closed -$709K 754
2015
Q2
$709K Sell
8,433
-7,887
-48% -$613K 0.06% 323
2015
Q1
$1.23M Buy
16,320
+7,998
+96% +$559K 0.11% 208
2014
Q4
$520K Buy
+8,322
New +$474K 0.05% 365
2013
Q4
Sell
-12,435
Closed -$536K 527
2013
Q3
$536K Buy
+12,435
New +$504K 0.1% 231

Other funds holding XBI